WO2005121863A1 - Automated diagnosis of malaria and other infections - Google Patents

Automated diagnosis of malaria and other infections Download PDF

Info

Publication number
WO2005121863A1
WO2005121863A1 PCT/ZA2005/000082 ZA2005000082W WO2005121863A1 WO 2005121863 A1 WO2005121863 A1 WO 2005121863A1 ZA 2005000082 W ZA2005000082 W ZA 2005000082W WO 2005121863 A1 WO2005121863 A1 WO 2005121863A1
Authority
WO
WIPO (PCT)
Prior art keywords
automated diagnosis
images
diagnosis
automated
image
Prior art date
Application number
PCT/ZA2005/000082
Other languages
French (fr)
Inventor
Nicholas Etienne Ross
David Milton Rubin
Charles John Pritchard
Original Assignee
Nicholas Etienne Ross
David Milton Rubin
Charles John Pritchard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Etienne Ross, David Milton Rubin, Charles John Pritchard filed Critical Nicholas Etienne Ross
Priority to EP05762647A priority Critical patent/EP1787156A1/en
Publication of WO2005121863A1 publication Critical patent/WO2005121863A1/en

Links

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/0004Microscopes specially adapted for specific applications
    • G02B21/0008Microscopes having a simple construction, e.g. portable microscopes
    • G01N15/1433
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N15/1468Electro-optical investigation, e.g. flow cytometers with spatial resolution of the texture or inner structure of the particle
    • G01N2015/1472Electro-optical investigation, e.g. flow cytometers with spatial resolution of the texture or inner structure of the particle with colour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • G01N2015/1497Particle shape
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This invention lies in the field of diagnosis and identification of micro-organisms and other objects.
  • the invention has particular application in the field of identification of infections and of pathological conditions, including by the automated visual identification of micro-organisms.
  • the invention is applicable over a range of organisms.
  • Infectious diseases such as malaria, tuberculosis and sexually transmitted infections (STI's) are a major global health problem, causing millions of deaths annually.
  • the economic effect of diseases such as malaria is also significant.
  • the control of these diseases requires a rapid and accurate diagnosis that facilitates prompt treatment.
  • microscopy Despite advances in diagnostic techniques for malaria and many other diseases, light microscopy remains the most widely and commonly used method. This entails examining thick and thin blood smears for the presence of Plasmodia. It is the most efficient and reliable diagnostic technique, with very high sensitivies and specificities. Microscopy also makes it possible to differentiate between species, quantify parasitaemia and observe asexual stages of the parasites. Low material costs mean that the marginal costs of tests are very low. Microscopy is labour intensive and time consuming and the accuracy of the final diagnosis ultimately depends on the skill and experience of the technician and the time spent studying each slide. Compared with expert microscopy, standard laboratory microscopy has a sensitivity of approximately 90 %, a figure that drops dramatically in the field. Variable smear quality and slide degeneration with time are also problematic.
  • Antigen and immunoassay based technologies have also been developed to provide simple 'dip stick' diagnoses for diseases such as malaria and chlamydia. These technologies are extremely portable and require very low levels of training, but have high per test costs and other limitations, such as the inability of malaria testing kits to simultaneously diagnose all species or quantify parasitaemia. In addition, a different test is also required for every disease for which a diagnosis is attempted.
  • This invention describes a system to improve upon infectious disease diagnosis by microscopy by removing its most serious limitation, viz. reliance on diagnosis by a human operator. This is achieved by developing a digital image processing system to automate the examination of samples such as (but not limited to) blood, sputum or cervical smears. To be successful, the system must provide at least the same diagnostic information as would normally be provided by a human operator. For example, in the case of malaria, it should give a positive or negative diagnosis of malaria with similar sensitivity and specificity to normal microscopy, differentiate parasites by species and quantify the degree of parasitaemia.
  • Chlamydia Chlamydia, gonorrhea, syphilis or tuberculosis, or parasites such as malaria, bilharzias, leishmaniasis and African trypanosomiasis.
  • the term "germ” will be used herein to encompass any micro-organism or object that the invention can be applied to.
  • a process in accordance with this invention includes the steps of : - capturing images of a germ from suitably prepared sample slides using an automated microscope; and analyzing the images using specially designed algorithms on a computing platform, whereby images are: pre-processed using filters such as median and morphological filters; analysed for relevant information, such as using granulometry to determine object radii; segmented using various novel threshold selection methods; characterized using features generated from first and second order statistical properties of the objects; and classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
  • filters such as median and morphological filters
  • relevant information such as using granulometry to determine object radii
  • segmented using various novel threshold selection methods characterized using features generated from first and second order statistical properties of the objects
  • classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
  • the system of this invention enables the automatic identification and diagnosis of said diseases and the yielding of other diagnostic information, such as parasite load and species in the case of malaria.
  • the capturing of images preferably uses a novel, simple auto configuration of microscope.
  • the characterising step may also include novel features that quantify criteria examined by human technicians during manual analysis.
  • Apparatus in accordance with this invention incorporates an image acquisition platform that captures microscopic images from a sample slide in an automated, systematic manner and then processes these images on a computing platform using image classification algorithms. Rather than simply being a diagnostic aid to a skilled technician by semi- automating the process and identifying areas of interest, the system is able to replace the technician and completely perform the diagnosis.
  • the system also benefits from a novel, simplified configuration that allows for tailored optics, improved ease of use and a more compact physical unit. In addition to the new physical configurations, the system utilizes novel image classification algorithms.
  • the ability to integrate a communications system into the invention also makes available a large number of other possibilities such as health reports; remote maintenance and software upgrades; and the remote collection of image samples for scientific purposes. Among other things this will also assist health authorities with, for instance, disease incidence monitoring and optimal allocation of resources.
  • the communications module can utilize a range of current or future communications technologies, such as without limitation: GPRS, satellite communications, GSM, Ethernet or WiFi.
  • GPRS Global System for Mobile communications
  • satellite communications such as Global System for Mobile communications
  • GSM Global System for Mobile communications
  • Ethernet such as Ethernet
  • WiFi Wireless Fidelity
  • the input to the system is a suitably stained slide for the targeted disease.
  • the slides used are thin blood films, which are routinely stained using the quickdiff protocol, although alternative staining protocols such as the more conventional Giemsa stain are also possible.
  • a Gram stain or a commercially available immunoassay such as the MikroTrak Chlamydia trachomatis Direct Specimen Test (Syva Co.) could be used, and for tuberculosis a suitable stain could be a sputum sample stained using, for example, the Ziehl-Neelsen or Auramine stains.
  • the input to the system - a suitably stained slide for the target disease - is the same as a technician using a light microscope would use, it can be seamlessly integrated into any existing diagnostic process that is based on light microscopy. This allows a very simple operating process to be used, whereby a sample is prepared as normal for the diagnosis desired, the slide is then inserted into the device and a diagnostic algorithm selected. It is a significant change from current practice that this device performs the diagnosis rather than a technician using a microscope. This makes the invention very flexible (unlike light microscopy), a trained technician is not required) with a wide scope for use (suitable for any diagnosis where the target can be identified on a stained sample fixed to a slide).
  • a medical practitioner could review the diagnosis whether remotely (such as over the internet or other communications network) or at the place of use by means of a user interface, such as a PC-based graphical user interface (GUI).
  • GUI graphical user interface
  • the innovations disclosed enable vastly increased efficiency, greater robustness, ease of use and accuracy when compared to human diagnosis, and are more cost-effective.
  • the invention also drastically reduces the manpower requirements required for the diagnostic process, leading to savings and releasing capacity from existing diagnostic operations, as well as making it possible to have accurate, point-of-care diagnosis in many areas that previously have lacked the necessary manpower resources.
  • Figure 1 shows a possible configuration of a system embodying the elements of this invention.
  • Figure 2 is a flow chart showing the operation of the image acquisition hardware.
  • Figure 3 shows a comparison of the image classification algorithms for the general case, malaria and chlamydia.
  • Figure 4 shows a design concept that is a possible embodiment of the invention in a robust, portable unit.
  • Figure 5 shows the results from some of the steps of applying the malaria algorithm to a sample image.
  • FIGURE 1 Microscopic images from a suitably stained slide 7 for a target disease are automatically captured by the image acquisition hardware.
  • the hardware consists of a simplified microscope (a tube 5 and lenses 4 with suitable magnification) connected to an image capture device 6; and a stage 1 moveable in the XY-plane to move the microscope field around the slide, and moveable along the Z-axis to allow for autofocus, onto which the slide is loaded.
  • Control software controls the movement of the stage and the operation of the image capture device.
  • a light source 8 and filter 9 is also provided.
  • a possible configuration could be a charge-couple device (CCD) camera connected to a microscope with 1000X magnification, a halogen lamp light source and a stage moveable along the X-, Y- and Z-axes.
  • CCD charge-couple device
  • the operation of the image acquisition software is such that a series of images 11 is captured from the slide 7 and passed to the relevant diagnostic algorithm 12 until the algorithm indicates that a diagnosis has been made and no more information is required.
  • a positive diagnosis could be signaled once several plasmodia have been identified and their species determined, and the level of parasitaemia ascertained.
  • a negative diagnosis could be signaled when, for example, ten thousand fields have been examined without finding any parasites.
  • chlamydia the presence of as few as ten elementary bodies (EB's) could signal a positive sample, while again a negative sample would require that a large number of fields have been investigated without detecting pathogens.
  • the images, once captured, are passed to an image classification algorithm shown in the figure that processes them sequentially.
  • the general structure of the image classification algorithm is in the form of a pattern recognition and classification system. This consists of a number of stages: image acquisition (implemented by the hardware platform); pre-processing 13 and image analysis 14; image segmentation 15; feature generation 16; and classification 17.
  • image acquisition is implemented by the hardware platform
  • pre-processing 13 and image analysis 14 image segmentation 15
  • feature generation 16 feature generation
  • classification 17 classification 17.
  • each algorithm is unique and specific to a target disease, but at the same time can all be used on the hardware platform since their input is simply a sequence of images of the sample slide.
  • the actual implementation of the image processing algorithms can differ for different diseases.
  • the first stage 17 of the malaria algorithm involves the use of a median filter to remove noise from the image.
  • a morphological area closing filter is also used to generate an image with less detail that is used for certain operations such as erythrocyte segmentation.
  • the pre-processing would also involve using suitable median, morphological or other filter implementations to generate an image that can be used for segmentation.
  • image analysis is not necessarily required for all diseases (for example chlamydia), but is required for diseases such as malaria since the morphological methods used for image segmentation depend on the size and shape of the objects in the image.
  • the size and eccentricity of the erythrocytes is also an important feature for differentiating malaria parasite species.
  • Granulometry is used to generate a pattern spectrum that indicates the size distribution of circular objects present in the image, from which the mean erythrocyte radius can be determined.
  • the average eccentricity of erythrocytes is determined by the ratio of major to minor axes of cells that are adjudged to be free-standing by virtue of their area.
  • An upper limit on the area of an erythrocyte in order for it to be considered free- standing can be calculated from the pattern spectrum, which indicates the mean and standard deviation of the radii of erythrocytes present in an image.
  • the granulometry and eccentricity measures are carried out on binary masks.
  • a threshold that separates the two principal modes - background and foreground - that are present in the image is used to obtain the mask.
  • Figure 5a shows a sample image, with malaria parasites that are to be automatically identified circled.
  • the next stage of the algorithm is image segmentation.
  • image segmentation For chlamydia, for example, this might only involve a threshold selection method to generate a mask of EB's present, based on the staining of the EB's, and a morphological filteY to ' remove any objects of incorrect size.
  • this step is more complicated and requires that potential parasites and erythrocytes are identified and segmented from the image, so that the infected erythrocytes can be extracted.
  • Erythrocytes are identified using a threshold that separates the two principal modes - the background and the erythrocytes - that are present in the image histogram (Figure 5b). Morphological filters are then applied to remove small artifacts and smooth the objects present in the mask ( Figure 5c). Parasites are identified using another threshold technique (Figure 5d), derived from the histogram of the green colour component of the image.
  • the mask of possible parasites is sued as a marker (figure 5e) to eliminate all erythrocytes from the erythrocyte mask that are not suspected of infection (Figure 5c).
  • the infected objects often consist of clumps of overlapping erythrocytes, and it is necessary to separate them.
  • a morphological gradient of the greyscale, morphologically filtered green component of the image is constructed by finding the difference between the dilation and erosion of the image. An intersection of the morphological gradient image and the dilated infected cell cluster is used to generate a mask of infected erythrocytes (Figure 5f).
  • relevant features include, amongst others, the colour, shape, size and relative position of objects to each other.
  • features generated from the infected erythrocytes include but are not limited to first and second order statistical measures that provide quantitative measures of the colour and texture of the objects. Other features are generated that are similar to the specific indicators used by a technician to determine parasite species, such as the size of the parasite, the size of the infected erythrocyte and the position of the parasite in the infected erythrocyte. These features are largely generated from binary masks of the plasmodia and infected erythrocytes, and are novel compared to most other feature generation methods in that rather than making statistical measures of image properties, they quantify measures that are consciously assessed by a human technician when making a diagnosis.
  • the final step in the image classification is the classification of the objects based on the feature vectors.
  • a single neural network classifier would be a suitable solution.
  • the first neural network uses predominantly colour and texture information to separate out false positives (Figure 5h), and the second neural network classifies the plasmodia according to species.
  • a number of embodiments of the described invention can be realized. These include, but are not limited to, use as a diagnostic tool, where the device makes an independent diagnosis from the given information, and as a diagnostic aid, where the device makes an assessment that is reviewed by a medical practitioner.
  • Figure 4 One possible realization of the device, embodying the invention described, is shown in Figure 4. As shown in this realization, the invention can be integrated into a robust, portable design that allows it to be used in a wide variety of locations. Since the skill level to prepare slides is far lower than that required to analyse slides and make a diagnosis, the diagnostic process using light microscopy can be extended to many locations where it has previously been unfeasible.
  • the result from the diagnosis may be conveyed using a user interface.
  • a user interface For example, this could take the form of a graphical user interface (GUI) on a liquid crystal display (LCD).
  • GUI graphical user interface
  • LCD liquid crystal display
  • An embodiment of the device could also include a communications module, as indicated in Figure 1 , which allows the invention to form the basis for a wider health monitoring network, for example disease incidence management by health authorities.
  • the ability to store results and the development of novel user interfaces can extend an additional embodiment of the device to include patient management. Parasite load can be provided as further diagnostic information and species as for example in the case of malaria.

Abstract

A process and apparatus for automated diagnosis of infections, using an image acquisition platform that captures microscopic images from a sample slide in an automated, systematic manner and then processes these images on a computing platform using image classification algorithms.

Description

FIELD OF INVENTION
This invention lies in the field of diagnosis and identification of micro-organisms and other objects. The invention has particular application in the field of identification of infections and of pathological conditions, including by the automated visual identification of micro-organisms. The invention is applicable over a range of organisms.
BACKGROUND
Infectious diseases, such as malaria, tuberculosis and sexually transmitted infections (STI's), are a major global health problem, causing millions of deaths annually. The economic effect of diseases such as malaria is also significant. The control of these diseases requires a rapid and accurate diagnosis that facilitates prompt treatment.
Despite advances in diagnostic techniques for malaria and many other diseases, light microscopy remains the most widely and commonly used method. This entails examining thick and thin blood smears for the presence of Plasmodia. It is the most efficient and reliable diagnostic technique, with very high sensitivies and specificities. Microscopy also makes it possible to differentiate between species, quantify parasitaemia and observe asexual stages of the parasites. Low material costs mean that the marginal costs of tests are very low. Microscopy is labour intensive and time consuming and the accuracy of the final diagnosis ultimately depends on the skill and experience of the technician and the time spent studying each slide. Compared with expert microscopy, standard laboratory microscopy has a sensitivity of approximately 90 %, a figure that drops dramatically in the field. Variable smear quality and slide degeneration with time are also problematic.
Antigen and immunoassay based technologies have also been developed to provide simple 'dip stick' diagnoses for diseases such as malaria and chlamydia. These technologies are extremely portable and require very low levels of training, but have high per test costs and other limitations, such as the inability of malaria testing kits to simultaneously diagnose all species or quantify parasitaemia. In addition, a different test is also required for every disease for which a diagnosis is attempted.
Some novel diagnostic tests have been developed that use, for example in the case of malaria, a cell counter to perform the diagnosis. None of these methods are known to be in use commercially, and the requirement to have a cell counter or other similarly complicated equipment available makes them unsuitable for use in any but the largest medical laboratories. THE INVENTION
This invention describes a system to improve upon infectious disease diagnosis by microscopy by removing its most serious limitation, viz. reliance on diagnosis by a human operator. This is achieved by developing a digital image processing system to automate the examination of samples such as (but not limited to) blood, sputum or cervical smears. To be successful, the system must provide at least the same diagnostic information as would normally be provided by a human operator. For example, in the case of malaria, it should give a positive or negative diagnosis of malaria with similar sensitivity and specificity to normal microscopy, differentiate parasites by species and quantify the degree of parasitaemia.
Further examples of conditions that the invention is well adapted to be applied to are Chlamydia, gonorrhea, syphilis or tuberculosis, or parasites such as malaria, bilharzias, leishmaniasis and African trypanosomiasis. The term "germ" will be used herein to encompass any micro-organism or object that the invention can be applied to.
A process in accordance with this invention includes the steps of : - capturing images of a germ from suitably prepared sample slides using an automated microscope; and analyzing the images using specially designed algorithms on a computing platform, whereby images are: pre-processed using filters such as median and morphological filters; analysed for relevant information, such as using granulometry to determine object radii; segmented using various novel threshold selection methods; characterized using features generated from first and second order statistical properties of the objects; and classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
The system of this invention enables the automatic identification and diagnosis of said diseases and the yielding of other diagnostic information, such as parasite load and species in the case of malaria.
The capturing of images preferably uses a novel, simple auto configuration of microscope. The characterising step may also include novel features that quantify criteria examined by human technicians during manual analysis.
Apparatus in accordance with this invention incorporates an image acquisition platform that captures microscopic images from a sample slide in an automated, systematic manner and then processes these images on a computing platform using image classification algorithms. Rather than simply being a diagnostic aid to a skilled technician by semi- automating the process and identifying areas of interest, the system is able to replace the technician and completely perform the diagnosis. The system also benefits from a novel, simplified configuration that allows for tailored optics, improved ease of use and a more compact physical unit. In addition to the new physical configurations, the system utilizes novel image classification algorithms.
The ability to integrate a communications system into the invention also makes available a large number of other possibilities such as health reports; remote maintenance and software upgrades; and the remote collection of image samples for scientific purposes. Among other things this will also assist health authorities with, for instance, disease incidence monitoring and optimal allocation of resources.
The communications module can utilize a range of current or future communications technologies, such as without limitation: GPRS, satellite communications, GSM, Ethernet or WiFi. By incorporating a modular design, the technology used can be customized to best fit the communications infrastructure of any particular area of development.
The input to the system is a suitably stained slide for the targeted disease. For example, for malaria the slides used are thin blood films, which are routinely stained using the quickdiff protocol, although alternative staining protocols such as the more conventional Giemsa stain are also possible. In the example of chlamydia, a Gram stain or a commercially available immunoassay such as the MikroTrak Chlamydia trachomatis Direct Specimen Test (Syva Co.) could be used, and for tuberculosis a suitable stain could be a sputum sample stained using, for example, the Ziehl-Neelsen or Auramine stains.
Since the input to the system - a suitably stained slide for the target disease - is the same as a technician using a light microscope would use, it can be seamlessly integrated into any existing diagnostic process that is based on light microscopy. This allows a very simple operating process to be used, whereby a sample is prepared as normal for the diagnosis desired, the slide is then inserted into the device and a diagnostic algorithm selected. It is a significant change from current practice that this device performs the diagnosis rather than a technician using a microscope. This makes the invention very flexible (unlike light microscopy), a trained technician is not required) with a wide scope for use (suitable for any diagnosis where the target can be identified on a stained sample fixed to a slide). If desired, a medical practitioner could review the diagnosis whether remotely (such as over the internet or other communications network) or at the place of use by means of a user interface, such as a PC-based graphical user interface (GUI). The innovations disclosed enable vastly increased efficiency, greater robustness, ease of use and accuracy when compared to human diagnosis, and are more cost-effective. The invention also drastically reduces the manpower requirements required for the diagnostic process, leading to savings and releasing capacity from existing diagnostic operations, as well as making it possible to have accurate, point-of-care diagnosis in many areas that previously have lacked the necessary manpower resources.
BRIEF DESCRIPTION OF THE DRAWINGS:
Figure 1 shows a possible configuration of a system embodying the elements of this invention.
Figure 2 is a flow chart showing the operation of the image acquisition hardware.
Figure 3 shows a comparison of the image classification algorithms for the general case, malaria and chlamydia.
Figure 4 shows a design concept that is a possible embodiment of the invention in a robust, portable unit.
Figure 5 shows the results from some of the steps of applying the malaria algorithm to a sample image. DETAILED DESCRIPTION OF THE INVENTION
REFERRING TO FIGURE 1 : Microscopic images from a suitably stained slide 7 for a target disease are automatically captured by the image acquisition hardware. The hardware consists of a simplified microscope (a tube 5 and lenses 4 with suitable magnification) connected to an image capture device 6; and a stage 1 moveable in the XY-plane to move the microscope field around the slide, and moveable along the Z-axis to allow for autofocus, onto which the slide is loaded. Control software controls the movement of the stage and the operation of the image capture device. A light source 8 and filter 9 is also provided. For example, without limitation, a possible configuration could be a charge-couple device (CCD) camera connected to a microscope with 1000X magnification, a halogen lamp light source and a stage moveable along the X-, Y- and Z-axes.
Although this kind of automated microscope is known, this particular configuration is novel in its simplicity: the specification of the image acquisition hardware is just to capture a sequence of digital images from the slide at the designed magnification. This means that simpler optics could be used (using only one objective) than in regular automated microscopes. By contrast to other approaches where, for example, images are precisely captured and stitched together to create a digital map of an entire sample, the location and neighbourhood of images captured in this system are not important, since each image is independently assessed by the selected diagnostic algorithm and all images are equally valid. This means that in theory the movement in the XY-plane to the next field-of-view could be arbitrary, but in practice a systematic method would be used to ensure that no fields are repeated so that every image adds new information and the efficiency of the system is maximized. The important consequence of this is that XY-plane movements need not be as precise as current systems require, since a slight overlapping or slight break between adjacent fields is not important, which allows a simpler, cheaper design for the automated stage. The simple design makes it possible to integrate the hardware into a compact design that can be used in a variety of locations.
The process steps implemented in the apparatus are indicated on the tabulated format at 10.
The inclusion of wide-area communications capacity as well as storage and a novel user interface means that the device can become extended from a diagnostic device to also be used for patient management and remote health reporting. RFERRING TO FIGURE 2 :
The operation of the image acquisition software is such that a series of images 11 is captured from the slide 7 and passed to the relevant diagnostic algorithm 12 until the algorithm indicates that a diagnosis has been made and no more information is required.
For example, in malaria, a positive diagnosis could be signaled once several plasmodia have been identified and their species determined, and the level of parasitaemia ascertained. A negative diagnosis could be signaled when, for example, ten thousand fields have been examined without finding any parasites. As another example, in chlamydia the presence of as few as ten elementary bodies (EB's) could signal a positive sample, while again a negative sample would require that a large number of fields have been investigated without detecting pathogens.
The ability to scan and process images sequentially means that the number of fields examined can be increased to as many as is desired, limited only by the area of the sample on the slide. This allows the device to improve upon current diagnostic methods. For example, by scanning a large number of fields in malaria, the sensitivity of the overall diagnosis, which is a function of the sensitivity of the diagnostic algorithm and the number of fields examined, can be made high enough to detect infections even at very low parasite loads. In current manual practice the entire slide is almost never examined.
The innovation detailed herein also allows microscope technology to be extended to diseases in which it is not commonly used. In the diagnosis of chlamydia, for example, it is considered too tedious for a technician to search through a slide for the presence of stained or fluorescent EB's. Under the scheme described in this patent, this becomes possible in an automated or semi-automated manner.
The speed of diagnosis is also increased, since the system is not constrained by factors such as operator fatigue. This also improves consistency of performance.
REFERRING TO FIGURE 3 :
The images, once captured, are passed to an image classification algorithm shown in the figure that processes them sequentially. The general structure of the image classification algorithm is in the form of a pattern recognition and classification system. This consists of a number of stages: image acquisition (implemented by the hardware platform); pre-processing 13 and image analysis 14; image segmentation 15; feature generation 16; and classification 17. Although based on tested pattern recognition and classification techniques, each algorithm is unique and specific to a target disease, but at the same time can all be used on the hardware platform since their input is simply a sequence of images of the sample slide. The actual implementation of the image processing algorithms can differ for different diseases. For malaria (Figure 3a), for example, the algorithm identifies erythrocytes (red blood cells) and malaria parasites present in the images, and from this information makes a diagnosis as to whether or not malaria is present, and if present, determines the species of the malaria and calculates the level of parasitaemia.
The desired effect, automated diagnosis of a disease or infection, is achieved by the software using, without limitation, a variety of filtering, analysis, segmentation, marking and classification steps as described below in more detail:
The first stage 17 of the malaria algorithm, pre-processing, involves the use of a median filter to remove noise from the image. A morphological area closing filter is also used to generate an image with less detail that is used for certain operations such as erythrocyte segmentation. For chlamydia (Figure 3b), as another example, the pre-processing would also involve using suitable median, morphological or other filter implementations to generate an image that can be used for segmentation.
The following step, image analysis, is not necessarily required for all diseases (for example chlamydia), but is required for diseases such as malaria since the morphological methods used for image segmentation depend on the size and shape of the objects in the image. The size and eccentricity of the erythrocytes is also an important feature for differentiating malaria parasite species. Granulometry is used to generate a pattern spectrum that indicates the size distribution of circular objects present in the image, from which the mean erythrocyte radius can be determined.
The average eccentricity of erythrocytes is determined by the ratio of major to minor axes of cells that are adjudged to be free-standing by virtue of their area. An upper limit on the area of an erythrocyte in order for it to be considered free- standing can be calculated from the pattern spectrum, which indicates the mean and standard deviation of the radii of erythrocytes present in an image.
The granulometry and eccentricity measures are carried out on binary masks. A threshold that separates the two principal modes - background and foreground - that are present in the image is used to obtain the mask.
REFERRING ALSO TO FIGURE 5 :
Figure 5a shows a sample image, with malaria parasites that are to be automatically identified circled. The next stage of the algorithm is image segmentation. For chlamydia, for example, this might only involve a threshold selection method to generate a mask of EB's present, based on the staining of the EB's, and a morphological filteY to ' remove any objects of incorrect size. For the example of malaria, this step is more complicated and requires that potential parasites and erythrocytes are identified and segmented from the image, so that the infected erythrocytes can be extracted. Erythrocytes are identified using a threshold that separates the two principal modes - the background and the erythrocytes - that are present in the image histogram (Figure 5b). Morphological filters are then applied to remove small artifacts and smooth the objects present in the mask (Figure 5c). Parasites are identified using another threshold technique (Figure 5d), derived from the histogram of the green colour component of the image.
Continuing the malaria example, the mask of possible parasites is sued as a marker (figure 5e) to eliminate all erythrocytes from the erythrocyte mask that are not suspected of infection (Figure 5c). The infected objects often consist of clumps of overlapping erythrocytes, and it is necessary to separate them. To do this, a morphological gradient of the greyscale, morphologically filtered green component of the image is constructed by finding the difference between the dilation and erosion of the image. An intersection of the morphological gradient image and the dilated infected cell cluster is used to generate a mask of infected erythrocytes (Figure 5f).
The next step of the algorithm is to generate features that can be used to correctly classify the objects segmented from the image. Our novel approach is to generate first and second order features from characteristics such as texture and colour, and to also generate features that quantify details that a human technician would assess when analyzing a sample. These could include, for example, the relative size of infected cells, the shape and size of possible pathogens and even the spacing between objects that have been identified.
In the case of chlamydia, for example, relevant features include, amongst others, the colour, shape, size and relative position of objects to each other.
In the case of malaria, features generated from the infected erythrocytes include but are not limited to first and second order statistical measures that provide quantitative measures of the colour and texture of the objects. Other features are generated that are similar to the specific indicators used by a technician to determine parasite species, such as the size of the parasite, the size of the infected erythrocyte and the position of the parasite in the infected erythrocyte. These features are largely generated from binary masks of the plasmodia and infected erythrocytes, and are novel compared to most other feature generation methods in that rather than making statistical measures of image properties, they quantify measures that are consciously assessed by a human technician when making a diagnosis.
The final step in the image classification is the classification of the objects based on the feature vectors. For the example of chlamydia, a single neural network classifier would be a suitable solution. For malaria, since there are two classifications occurring, without limitation two neural networks in a binary tree structure are used. The first neural network uses predominantly colour and texture information to separate out false positives (Figure 5h), and the second neural network classifies the plasmodia according to species.
A number of embodiments of the described invention can be realized. These include, but are not limited to, use as a diagnostic tool, where the device makes an independent diagnosis from the given information, and as a diagnostic aid, where the device makes an assessment that is reviewed by a medical practitioner.
REFERRING TO FIGURE 4 :
One possible realization of the device, embodying the invention described, is shown in Figure 4. As shown in this realization, the invention can be integrated into a robust, portable design that allows it to be used in a wide variety of locations. Since the skill level to prepare slides is far lower than that required to analyse slides and make a diagnosis, the diagnostic process using light microscopy can be extended to many locations where it has previously been unfeasible.
The result from the diagnosis may be conveyed using a user interface. For example, this could take the form of a graphical user interface (GUI) on a liquid crystal display (LCD). An embodiment of the device could also include a communications module, as indicated in Figure 1 , which allows the invention to form the basis for a wider health monitoring network, for example disease incidence management by health authorities. The ability to store results and the development of novel user interfaces can extend an additional embodiment of the device to include patient management. Parasite load can be provided as further diagnostic information and species as for example in the case of malaria.

Claims

CLAIMS:
1. A process of automated diagnosis, which includes the steps of : - - capturing images of a germ from suitably prepared sample slides using a automated microscope; and analyzing the images using specially designed algorithms on a computing platform.
2. A process of automated diagnosis as claimed in claim 1 , in which the images are pre-processed using filters such as median and morphological filters.
3. A process of automated diagnosis as claimed in either one of claim 1 or 2, in which the images are analysed for relevant information using granulometry to determine object radii.
4. A process of automated diagnosis as claimed in any one of claims 1 to 3, in which the images are segmented using various novel threshold selection methods.
5. A process of automated diagnosis as claimed in any one of claims 1 to 4, in which the images are characterized using features generated from first and second order statistical properties of the objects.
6. A process of automated diagnosis as claimed in any one of claims 1 to 5, in which the images are classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
7. A process as claimed in any one of claims 1 to 6, which provides a yield of further diagnostic information, including parasite load and species, in applicable cases.
8. A process as claimed in any one of claims 1 to 7, which stores information generated by the process to aid in patient management and to be communicated to required destinations.
9. A process of automated diagnosis as claimed in any one of claims 1 to 8, in which eccentricity is determined in the images captured by the ratio of minor axis to major axis of cells that are adjudged to be free standing by virtue of their area.
10. A process of automated diagnosis as claimed in any one of claims 3 to 9, in which granulometry measures are carried out on binary masks in the images captured.
11. A process of automated diagnosis as claimed in either one of claims 9 or 10, in which eccentricity measures are carried out on binary masks in the images captured.
12. A process of automated diagnosis as claimed in any one of claims 1 to 11 , in which eccentricity is determined in the images captured, by the ratio of major to minor axes of cells that are adjudged to be free-standing by virtue of their area.
13. A process of automated diagnosis as claimed in any one of claims 1 to 12, in which granulometry measures are carried out on binary masks in the images captured.
14. A process of automated diagnosis as claimed in any one of claims 1 to 13, in which eccentricity measures are carried out on binary masks in the images captured.
15. A process of automated diagnosis as claimed in any one of claims 1 to 14, in which an automatic calculation whether an object is free standing by assessment of the pattern spectrum, indicating the mean and standard deviation of the radii of objects present in images captured, is carried out.
16. A process of automated diagnosis as claimed in any one of claims 1 to 15, in which image segmentation techniques, including threshold selection methods, are used to identify target objects.
17. A process of automated diagnosis as claimed in claim 16, in which morphological filters and the like are used to remove any objects of incorrect size in the images captured.
18. A process of automated diagnosis as claimed in any one of claims 1 to 17, in which morphological filters are used to remove artefacts and objects present in the mask.
19. A process of automated diagnosis as claimed in any one of claims 1 to 18, in which malaria parasites are identified using another threshold technique, derived from the histogram of the green colour component of the image. '
20. A process of automated diagnosis as claimed in any one of claims 1 to 19, in which separation of clumps of infected objects is achieved using a morphological gradient of the greyscale.
21. A process of automated diagnosis as claimed in claim 20, in which, the morphologically filtered green component of the image is constructed by finding the difference between the dilation and erosion of the image.
22. A process of automated diagnosis as claimed in claim 21 , in which an intersection of the morphological gradient image and the dilated infected cell cluster is used to generate a mask of infected erythrocytes.
23. A process of automated diagnosis as claimed in any one of claims 1 to 22, in which features are generated to correctly classify the objects segmented from the image, the features including, the colour, shape, size, texture and relative position of objects to each other.
24. A process of automated diagnosis as claimed in claim 23, in which objects are classified based on the feature vectors.
25. A process of automated diagnosis as claimed in claim 24, in which in chlamydia, a single neural network classifier is used.
26. A process of automated diagnosis as claimed in claim 24, in which for malaria, two neural networks in a binary tree structure are used, the first neural network using predominantly colour and texture information to separate out false positives, and the second neural network classifying the plasmodia according to species.
27. A process of automated diagnosis as claimed in any one of claims 1 to 26, in which patient details and results are stored.
28. A process of automated diagnosis as claimed in any one of claims 1 to 27, in which a custom user interface is used for patient management.
29. A process of automated diagnosis as claimed in any one of claims 1 to 28, in which a communications module is integrated.
30. A process of automated diagnosis as claimed in any one of claims 1 to 29, in which diagnostic results are communicated to a central authority to facilitate health reporting and disease incidence management.
31. A process of automated diagnosis as claimed in any one of claims 1 to 30, in which software updates are performed remotely and system operation is checked and assessed remotely.
32. A process of automated diagnosis as claimed in any one of claims 1 to 31 , in which images are collected remotely for scientific and other purposes.
33. A process as herein described.
34. Apparatus for carrying out the process as claimed in any one of claims 1 to 32, which incorporates an image acquisition platform that captures microscopic images from a sample slide in an automated, systematic manner and then processes these images on a computing platform using image classification algorithms.
35. Apparatus as herein described and as illustrated in the drawings.
PCT/ZA2005/000082 2004-06-11 2005-06-10 Automated diagnosis of malaria and other infections WO2005121863A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05762647A EP1787156A1 (en) 2004-06-11 2005-06-10 Automated diagnosis of malaria and other infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA2004/04669 2004-06-11
ZA200404669 2004-06-11

Publications (1)

Publication Number Publication Date
WO2005121863A1 true WO2005121863A1 (en) 2005-12-22

Family

ID=34981227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2005/000082 WO2005121863A1 (en) 2004-06-11 2005-06-10 Automated diagnosis of malaria and other infections

Country Status (2)

Country Link
EP (1) EP1787156A1 (en)
WO (1) WO2005121863A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012085079A2 (en) 2010-12-22 2012-06-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device and method for determining objects in a colour photograph
WO2013142219A1 (en) * 2012-03-20 2013-09-26 The Regents Of The University Of California System and method for crowd-sourced telepathology
US9329129B2 (en) 2013-07-01 2016-05-03 S.D. Sight Diagnostics Ltd. Method, kit and system for imaging a blood sample
US10025902B2 (en) 2016-08-12 2018-07-17 Verily Life Sciences Llc Enhanced pathology diagnosis
US10176565B2 (en) 2013-05-23 2019-01-08 S.D. Sight Diagnostics Ltd. Method and system for imaging a cell sample
US10203491B2 (en) 2016-08-01 2019-02-12 Verily Life Sciences Llc Pathology data capture
US10482595B2 (en) 2014-08-27 2019-11-19 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
US10488644B2 (en) 2015-09-17 2019-11-26 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
US10640807B2 (en) 2011-12-29 2020-05-05 S.D. Sight Diagnostics Ltd Methods and systems for detecting a pathogen in a biological sample
US10831013B2 (en) 2013-08-26 2020-11-10 S.D. Sight Diagnostics Ltd. Digital microscopy systems, methods and computer program products
US10843190B2 (en) 2010-12-29 2020-11-24 S.D. Sight Diagnostics Ltd. Apparatus and method for analyzing a bodily sample
US11099175B2 (en) 2016-05-11 2021-08-24 S.D. Sight Diagnostics Ltd. Performing optical measurements on a sample
US11307196B2 (en) 2016-05-11 2022-04-19 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
US11609413B2 (en) 2017-11-14 2023-03-21 S.D. Sight Diagnostics Ltd. Sample carrier for microscopy and optical density measurements
US11733150B2 (en) 2016-03-30 2023-08-22 S.D. Sight Diagnostics Ltd. Distinguishing between blood sample components

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111577A1 (en) * 2008-03-04 2009-09-11 California Institute Of Technology Methods of using optofluidic microscope devices
US8039776B2 (en) 2008-05-05 2011-10-18 California Institute Of Technology Quantitative differential interference contrast (DIC) microscopy and photography based on wavefront sensors
US8660312B2 (en) 2009-01-21 2014-02-25 California Institute Of Technology Quantitative differential interference contrast (DIC) devices for computed depth sectioning
US8416400B2 (en) 2009-06-03 2013-04-09 California Institute Of Technology Wavefront imaging sensor
WO2011119678A2 (en) 2010-03-23 2011-09-29 California Institute Of Technology Super resolution optofluidic microscopes for 2d and 3d imaging

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175549A2 (en) * 1984-09-14 1986-03-26 Branko Palcic Dynamic microscope image processing scanner
EP0293083A2 (en) * 1987-04-30 1988-11-30 Corabi International Telemetrics, Inc. Remote transmission diagnostic system
US5134662A (en) * 1985-11-04 1992-07-28 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5187749A (en) * 1990-04-10 1993-02-16 Olympus Optical Co., Ltd. Virus infection examination apparatus having automatic determination function and method therefor
US6005964A (en) * 1996-01-24 1999-12-21 The Board Of Trustees Of The University Of Illinois Automatic machine vision microscope slide inspection system and method
WO2002037158A2 (en) * 2000-11-03 2002-05-10 Cytyc Corporation Cytological imaging systems and methods
WO2003102210A2 (en) * 2002-05-30 2003-12-11 The Johns Hopkins University Techniques for automated diagnosis of cell-borne anomalies with a digital optical microscope

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175549A2 (en) * 1984-09-14 1986-03-26 Branko Palcic Dynamic microscope image processing scanner
US5134662A (en) * 1985-11-04 1992-07-28 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
EP0293083A2 (en) * 1987-04-30 1988-11-30 Corabi International Telemetrics, Inc. Remote transmission diagnostic system
US5187749A (en) * 1990-04-10 1993-02-16 Olympus Optical Co., Ltd. Virus infection examination apparatus having automatic determination function and method therefor
US6005964A (en) * 1996-01-24 1999-12-21 The Board Of Trustees Of The University Of Illinois Automatic machine vision microscope slide inspection system and method
WO2002037158A2 (en) * 2000-11-03 2002-05-10 Cytyc Corporation Cytological imaging systems and methods
WO2003102210A2 (en) * 2002-05-30 2003-12-11 The Johns Hopkins University Techniques for automated diagnosis of cell-borne anomalies with a digital optical microscope

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010063965A1 (en) 2010-12-22 2012-06-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Apparatus and method for determining objects of a color photograph
US9196036B2 (en) 2010-12-22 2015-11-24 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Device and method for determining objects in a color recording
WO2012085079A2 (en) 2010-12-22 2012-06-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device and method for determining objects in a colour photograph
US10843190B2 (en) 2010-12-29 2020-11-24 S.D. Sight Diagnostics Ltd. Apparatus and method for analyzing a bodily sample
US11584950B2 (en) 2011-12-29 2023-02-21 S.D. Sight Diagnostics Ltd. Methods and systems for detecting entities in a biological sample
US10640807B2 (en) 2011-12-29 2020-05-05 S.D. Sight Diagnostics Ltd Methods and systems for detecting a pathogen in a biological sample
WO2013142219A1 (en) * 2012-03-20 2013-09-26 The Regents Of The University Of California System and method for crowd-sourced telepathology
US11100634B2 (en) 2013-05-23 2021-08-24 S.D. Sight Diagnostics Ltd. Method and system for imaging a cell sample
US11295440B2 (en) 2013-05-23 2022-04-05 S.D. Sight Diagnostics Ltd. Method and system for imaging a cell sample
US10176565B2 (en) 2013-05-23 2019-01-08 S.D. Sight Diagnostics Ltd. Method and system for imaging a cell sample
US11803964B2 (en) 2013-05-23 2023-10-31 S.D. Sight Diagnostics Ltd. Method and system for imaging a cell sample
US9329129B2 (en) 2013-07-01 2016-05-03 S.D. Sight Diagnostics Ltd. Method, kit and system for imaging a blood sample
US11434515B2 (en) 2013-07-01 2022-09-06 S.D. Sight Diagnostics Ltd. Method and system for imaging a blood sample
US10093957B2 (en) 2013-07-01 2018-10-09 S.D. Sight Diagnostics Ltd. Method, kit and system for imaging a blood sample
US10831013B2 (en) 2013-08-26 2020-11-10 S.D. Sight Diagnostics Ltd. Digital microscopy systems, methods and computer program products
US10482595B2 (en) 2014-08-27 2019-11-19 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
US11721018B2 (en) 2014-08-27 2023-08-08 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
US11100637B2 (en) 2014-08-27 2021-08-24 S.D. Sight Diagnostics Ltd. System and method for calculating focus variation for a digital microscope
US10663712B2 (en) 2015-09-17 2020-05-26 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
US11199690B2 (en) 2015-09-17 2021-12-14 S.D. Sight Diagnostics Ltd. Determining a degree of red blood cell deformity within a blood sample
US11262571B2 (en) 2015-09-17 2022-03-01 S.D. Sight Diagnostics Ltd. Determining a staining-quality parameter of a blood sample
US10488644B2 (en) 2015-09-17 2019-11-26 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
US11796788B2 (en) 2015-09-17 2023-10-24 S.D. Sight Diagnostics Ltd. Detecting a defect within a bodily sample
US11914133B2 (en) 2015-09-17 2024-02-27 S.D. Sight Diagnostics Ltd. Methods and apparatus for analyzing a bodily sample
US11733150B2 (en) 2016-03-30 2023-08-22 S.D. Sight Diagnostics Ltd. Distinguishing between blood sample components
US11099175B2 (en) 2016-05-11 2021-08-24 S.D. Sight Diagnostics Ltd. Performing optical measurements on a sample
US11307196B2 (en) 2016-05-11 2022-04-19 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
US11808758B2 (en) 2016-05-11 2023-11-07 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
US10545327B2 (en) 2016-08-01 2020-01-28 Verily Life Sciences Llc Pathology data capture
US10203491B2 (en) 2016-08-01 2019-02-12 Verily Life Sciences Llc Pathology data capture
US10262757B2 (en) 2016-08-12 2019-04-16 Verily Life Sciences Llc Enhanced pathology diagnosis
US11501871B2 (en) 2016-08-12 2022-11-15 Verily Life Sciences Llc Enhanced pathology diagnosis
US10025902B2 (en) 2016-08-12 2018-07-17 Verily Life Sciences Llc Enhanced pathology diagnosis
US11614609B2 (en) 2017-11-14 2023-03-28 S.D. Sight Diagnostics Ltd. Sample carrier for microscopy measurements
US11609413B2 (en) 2017-11-14 2023-03-21 S.D. Sight Diagnostics Ltd. Sample carrier for microscopy and optical density measurements
US11921272B2 (en) 2017-11-14 2024-03-05 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements

Also Published As

Publication number Publication date
EP1787156A1 (en) 2007-05-23

Similar Documents

Publication Publication Date Title
WO2005121863A1 (en) Automated diagnosis of malaria and other infections
US10677711B2 (en) Method and apparatus for automated whole blood sample analyses from microscopy images
EP3859425B1 (en) Methods and apparatus for detecting an entity in a bodily sample
EP2936116B1 (en) System and method for classification of particles in a fluid sample
US10083340B2 (en) Automated cell segmentation quality control
US5933519A (en) Cytological slide scoring apparatus
JP2007133859A (en) Automated,microscope-assisted examination process of tissue or bodily fluid samples
US20180156713A1 (en) Automated Slide Assessments and Tracking in Digital Microscopy
CN110473167A (en) A kind of urine sediment image identifying system and method based on deep learning
JPH09509487A (en) Cell sample automatic classification device and method
JP4864709B2 (en) A system for determining the staining quality of slides using a scatter plot distribution
KR20010017092A (en) Method for counting and analyzing morphology of blood cell automatically
KR101106386B1 (en) System for classifying slides using scatter plot distributions
US20190362491A1 (en) Computer-implemented apparatus and method for performing a genetic toxicity assay
US7257243B2 (en) Method for analyzing a biological sample
JPH07181123A (en) Particle image analyzer
JP2022121167A (en) Image processing device, control method of image processing device, and program
Samuel et al. Design to automate the detection and counting of Tuberculosis (TB) bacilli
EP4137795A1 (en) Fluorescence image analysis method, fluorescence image analyser, fluoresence image analysis program
Shah et al. Automated Hematology: Blood Cells Detection and Classification Using Deep Learning Algorithms
KR20230125999A (en) Immunofluorescence assay result reading apparatus using artificial intelligence and Reading and method thereof
Ahmed et al. Leukemia detection based on microscopic blood smear images using deep learning
EP4264494A1 (en) Automated microscopy
CN113344868A (en) Label-free cell classification screening system based on mixed transfer learning

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2005762647

Country of ref document: EP